Testing effectiveness (Phase 2)Study completedNCT01933334
What this trial is testing
Safety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
Who this might be right for
Systemic Sclerosis
Genentech, Inc. 63